Results 51 to 60 of about 7,733 (241)
OBJECTIVES/SPECIFIC AIMS: Morphea (localized scleroderma) is an autoimmune disease characterized that is widely thought to have a monophasic course, in which an initial period of inflammation (activity) ultimately results in scarring, atrophy, and ...
Stephanie Florez-Pollack+2 more
doaj +1 more source
MORPHEA-LIKE EPITHELIOMA [PDF]
Although the form of epithelioma about to be described in this paper presents such peculiar clinical features, it has not yet, so far as I know, been mentioned in text-books of surgery and is only very briefly alluded to in but one text-book of dermatology. I have, therefore, thought it might be of some interest to call attention to it very briefly and
openaire +3 more sources
Promoting the use of Motor Function Measure (MFM) as outcome measure in patients with Duchenne Muscular Dystrophy (DMD) treated by corticosteroids [PDF]
ObjectivesAssessing muscle function is a key step in measuring changes and evaluating the outcomes of therapeutic interventions in Duchenne Muscular Dystrophy (DMD).
Schreiber-Bontemps, A.+20 more
core +5 more sources
The Aetiology of Elevated Total Serum Immunoglobulin E in Children
ABSTRACT Aim The paucity of real‐world data on the aetiology of elevated total serum immunoglobulin E (TS‐IgE) in children afflicts families and health care systems with diagnostic uncertainty. We explored a cohort of children with TS‐IgE levels over 1000 kU/L, focusing on the prevalence of atopic and non‐atopic conditions, the aetiology of extremely ...
Aliisa Ärölä+2 more
wiley +1 more source
Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review
ABSTRACT The emergence of immune checkpoint inhibitors has revolutionized the landscape of cancer treatment in the modern era. However, cutaneous immune‐related adverse events (cirAEs) are common, significantly affecting patients' quality of life and often leading to treatment discontinuation, which may compromise oncological outcomes.
Ioannis‐Alexios Koumprentziotis+5 more
wiley +1 more source
A 69-year-old man presented with symmetric erythematous, hyperpigmented, and ivory-colored plaques on the trunk and extremities. His clinical history, laboratory analysis, and histopathologic examination were consistent with generalized morphea, a subtype of localized scleroderma.
openaire +4 more sources
Bullous hemorrhagic lichen sclerosus of the breast: a report of two cases and review of the literature [PDF]
Lichen sclerosus (LS) is a chronic dermatologic condition characterized by atrophic porcelain-appearing plaques that can cause intense discomfort and eventually lead to destruction of local architecture.
Kroger, Kathleen T+3 more
core
Pansclerotic morphea: A male child with hemiatrophy of lower limb
Morphea is a variant of localized scleroderma in which lesions are usually limited to the skin and subcutaneous tissue. Pansclerotic morphea is a rare atrophying and sclerosing type of morphea. It can follow a comparatively benign course with spontaneous
Malay K Dasgupta+3 more
doaj +1 more source
Muscle Vasculitis: A Novel Delineation of Distinct Subsets of Disease
Objective The objective of this study was to assess the clinical and histopathologic features of muscle vasculitis. Methods The electronic database of SA Pathology, wherein all muscle biopsy samples in South Australia are assessed, was searched (2000–2023), identifying cases of vasculitis.
Thomas Khoo+4 more
wiley +1 more source
Generalized Morphea after Breast Cancer Radiation Therapy
We present a case of a 69-year-old woman who received external beam radiation for the treatment of breast cancer. Seven months later, she developed generalized morphea involving the area of irradiated skin of the breast as well as distant sites of the ...
Jonathan Kushi, M. E. Csuka
doaj +1 more source